RIP3, a novel apoptosis-inducing kinase.
Article Details
- CitationCopy to clipboard
Sun X, Lee J, Navas T, Baldwin DT, Stewart TA, Dixit VM
RIP3, a novel apoptosis-inducing kinase.
J Biol Chem. 1999 Jun 11;274(24):16871-5.
- PubMed ID
- 10358032 [ View in PubMed]
- Abstract
RIP3 is a novel gene product containing a N-terminal kinase domain that shares extensive homology with the corresponding domain in RIP (receptor-interacting protein) and RIP2. Unlike RIP, which has a C-terminal death domain, and RIP2, which has a C-terminal caspase activation and recruitment domain, RIP3 has a unique C terminus. RIP3 binds RIP through its unique C-terminal segment and by virtue of this interaction is recruited to the tumor necrosis factor (TNF) receptor-1 signaling complex. Previous studies have shown that RIP mediates TNF-induced activation of the anti-apoptotic NF-kappaB pathway. RIP3, however, attenuates both RIP and TNF receptor-1-induced NF-kappaB activation. Overexpression studies revealed RIP3 to be a potent inducer of apoptosis, capable of selectively binding to large prodomain initiator caspases.